Gene · 3675
Papers2,788
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,788
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of Extracellular Vesicles Derived From Human Precision-Cut Liver Slices in Metabolic Dysfunction-Associated Steatotic Liver Disease. | J Extracell Biol | 2025 | 40313415 | PubTator, text mining | PubMed |
| Extracellular Vesicle Marker Changes Associated With Disease Activity in Relapsing-Remitting Multiple Sclerosis. | Neurol Neuroimmunol Neuroinflamm | 2025 | 40300121 | PubTator, text mining | PubMed |
| Evaluation of Integrin Glycovariants as Biomarkers of Metastasis, Invasion, and Therapy Stratification in Head and Neck Squamous Cell Carcinoma. | Cancer Med | 2025 | 40287842 | PubTator, text mining | PubMed |
| Sirtuin1 Promotes the Migration of Cells and Reduces the Accumulation of Extracellular Matrix in Trabecular Meshwork Cells Induced by Transform Growth Factor-β via Smads System. | Discov Med | 2025 | 40287804 | PubTator, text mining | PubMed |
| Engineered cytokine-expressing MSCs support ex vivo culture of human HSPCs and AML cells. | Exp Hematol | 2025 | 40274186 | PubTator, text mining | PubMed |
| A model of basement membrane-related regulators for prediction of prognoses in esophageal cancer and verification in vitro. | BMC Cancer | 2025 | 40234833 | PubTator, text mining | PubMed |
| ITGA1, the alpha 1 subunit of integrin receptor, is a novel marker of drug-resistant senescent melanoma cells in vitro. | Arch Toxicol | 2025 | 40202610 | PubTator, text mining | PubMed |
| Expression and clinical significance of ITGA3 in breast cancer. | Open Med (Wars) | 2025 | 40181838 | PubTator, text mining | PubMed |
| ITGA3-MET interaction promotes papillary thyroid cancer progression via ERK and PI3K/AKT pathways. | Ann Med | 2025 | 40138447 | PubTator, text mining | PubMed |
| Vitamin A-Enriched Diet Increases Urothelial Cell Proliferation by Upregulating Itga3 and Areg After Cyclophosphamide-Induced Injury in Mice. | Mol Nutr Food Res | 2025 | 40119798 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer. | Chin J Cancer Res | 2025 | 40078560 | PubTator, text mining | PubMed |
| Exosomal integrin alpha 3 promotes epithelial ovarian cancer cell migration via the S100A7/p-ERK signaling pathway. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 40055916 | PubTator, text mining | PubMed |
| Novel Compound Heterozygous Mutations in ILNEB Syndrome. | Australas J Dermatol | 2025 | 40019062 | PubTator, text mining | PubMed |
| Comparative RNA-Seq analysis of differentially expressed genes in the sertoli cells of yak and cattle-yak. | BMC Vet Res | 2025 | 39987073 | PubTator, text mining | PubMed |
| RNA binding protein Pumilio2 promotes chemoresistance of pancreatic cancer via focal adhesion pathway and interacting with transcription factor EGR1. | Cell Mol Life Sci | 2025 | 39961821 | PubTator, text mining | PubMed |
| The differential expression of circulating microRNAs in sickle cell trait compared with the normal hemoglobin phenotype. | Blood Adv | 2025 | 39938012 | PubTator, text mining | PubMed |
| 3D bioprinting lobule-like hepatorganoids with induced vascularization for orthotopic implantation. | Mater Today Bio | 2025 | 39911370 | PubTator, text mining | PubMed |
| Knockdown of LAMA3 enhances the sensitivity of colon cancer to oxaliplatin by regulating the Hippo-YAP pathway. | Biochim Biophys Acta Mol Basis Dis | 2025 | 39798821 | PubTator, text mining | PubMed |
| ITGA3 promotes pancreatic cancer progression through HIF1α- and c-Myc-driven glycolysis in a collagen I-dependent autocrine manner. | Cancer Gene Ther | 2025 | 39690180 | PubTator, text mining | PubMed |
| Podocyte YAP ablation decreases podocyte adhesion and exacerbates FSGS progression through α3β1 integrin. | J Pathol | 2025 | 39668547 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3675/papers?page=6